Results 151 to 160 of about 1,215,916 (294)
INCORPORATION OF AMINO ACIDS INTO SEA URCHIN EGGS STIMULATED INSUFFICIENTLY WITH AN ACTIVATING REAGENT [PDF]
Seiko Nakashima, Masao Sugiyama
openalex +1 more source
Clinical analysis reveals significant dysregulation of FGFRL1 in esophageal cancer (EC) patients. RNAi‐coupled next‐generation sequencing (NGS) and in vitro study reveal FGFRL1‐mediated EC progression via EMT, PI3K/Akt, and Notch pathways. Functional assays confirm its role in tumor growth, migration, and invasion.
Aprajita Srivastava +3 more
wiley +1 more source
Application of Anti-Immune Complex Reagents in Small Molecule Analyte Immunoassays
Kai Du +4 more
doaj +1 more source
Application of Gyrolab, an Automated Microfluidic System, to Regulated Bioanalysis of a Therapeutic Antibody in Monkey Serum. [PDF]
Nabeshima K, Kojima T, Mano Y.
europepmc +1 more source
New reagents. IX. Fluorinating reagents. Fluorinating reagent: DAST.
openaire +2 more sources
CRISPRI‐mediated gene silencing and phenotypic exploration in nontuberculous mycobacteria. In this Research Protocol, we describe approaches to control, monitor, and quantitatively assess CRISPRI‐mediated gene silencing in M. smegmatis and M. abscessus model organisms.
Vanessa Point +7 more
wiley +1 more source
Cu<sub>14</sub>H<sub>12</sub>(P<i><sup>t</sup></i>Bu<sub>3</sub>)<sub>6</sub>Cl<sub>2</sub>-The Expanse of Stryker's Reagent. [PDF]
Strienz M +3 more
europepmc +1 more source
New reagents. V. Reducing reagents. Reducing reagent tris(trimethyl)silane.
openaire +2 more sources
NF90–NF45 functions as a negative regulator of methyltransferase‐like 3/14 (METTL3/14)‐mediated N6‐methyladenosine (m6A) modification on primary microRNAs (pri‐miRNAs). NF90–NF45 binds to anti‐oncogenic pri‐miRNAs and inhibits their m6A modification, thereby suppressing the biogenesis of anti‐oncogenic miRNAs.
Takuma Higuchi +6 more
wiley +1 more source

